GlucoseSensor Market, by Product Type (Non-invasive (Optical Sensors andTransdermal Sensors), Invasive (Intravenous Implantable, Micro Dialysis, andSubcutaneous Sensor), and Minimally Invasive (Micro Pore/ Micro Needles)), byTechnology (Polarimetry, Raman Spectroscopy, (Near) Infrared Spectroscopy, MIRSpectroscopy, Impedance Spectroscopy, Fluorescence, Photo-AcousticSpectroscopy, Optical Coherence Tomography, Skin Suction Blister Technique,Sonophoresis, and Reverse Iontophoresis), by Distribution Channel (Hospitals,Clinics, Home Care Settings, and Others), and by Region (North America, Europe,Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook,and Opportunity Analysis, 2018 – 2026
Glucose sensors are insertedunder skin to measure glucose (sugar) levels. These sensors are connectedwirelessly to the continuous glucose monitoring system. They offer data to themonitoring system or smart compatible devices that aid to track the level ofblood glucose in a patient at regular intervals.
Global Glucose Sensor Market:Drivers
Increasing number of pipelinestudies to develop new glucose sensors is expected to boost the glucose sensormarket growth. For instance, in April 2018, University of California San Diego,in collaboration with National Institutes of Health (NIH), initiated theclinical study for adhesive glucose sensor to measure sweat glucose of patientswith diabetes. The main aim of this clinical study is to explore the accuracyand acceptability of a non-invasive, wearable glucose sensor in patients livingwith Diabetes Mellitus. The study is estimated to be completed by June 2019.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2490
Moreover, new product launchesfor measuring blood glucose levels is also expected to contribute to growth ofthe glucose sensor market size. For instance, in December 2018, Nemaura MedicalInc., a medical technology company developing sugarBEAT, signed licensing anddistribution agreement with Doha-based Al-Danah Medical Co. to commerciallylaunch sugarBEAT in Qatar by 2019. sugarBEAT is the first painless,non-invasive continuous glucose monitor (CGM) for use by diabetic andpre-diabetic patients.
Global Glucose Sensor Market:Regional Analysis
On the basis of region, theglobal glucose sensor market is segmented into North America, Latin America,Europe, Asia Pacific, Middle East, and Africa.
North America is expected towitness significant growth in the glucose sensor market, owing to presence ofmajor players and launch of new products in this region. For instance, in July2018, Abbott Laboratories received the U.S. Food and Drug Administration (FDA)approval for its FreeStyle Libre 14 day Flash Glucose Monitoring System. Thesystem allows a diabetic patient to wearthe sensor up to 14 days and offers results with high accuracy. It is the firstcontinuous glucose monitoring system that can be used by diabetic patients totake diabetes treatment decisions without using a blood sample from thefingertip.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/glucose-sensor-market-2490
The systems eliminates the needfor fingerstick testing by using a small sensor wire inserted below the skin’ssurface. This sensor continuously measures and monitors glucose levels.
Furthermore, Asia Pacific glucosesensor market is expected to witness significant growth over the forecastperiod, owing to increasing diabetes healthcare spending in the region. Forinstance, according to the International Diabetes Federation’ (IDF) estimates,in 2017, diabetic healthcare spending in Asia Pacific was US$ 241 million.
Key players operating in theglobal glucose sensor market include, Abbott Diagnostics, PinnacleTechnologies, Inc., 77 Elektronika KFT, Sanofi-Deutschland GmbH, Life Scan(Johnson and Johnson Company), Universal Biosensors, Diamontech GmbH, MedicalWireless Sensing Ltd, Medtronic MiniMed, Inc. Bayer Healthcare, DexCom Inc.,Nova Biomedical Corporation, Terumo Europe NV, Arkay, Inc., and RocheDiagnostics.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2490
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
